Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
T
Tomohiro Morio
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
580
Papers
27.0K
Citations
68
h-index
266
i10-index
Tomohiro Morio is an academic researcher from Tokyo Institute of Psychiatry. The author has contributed to research in topics: Immunodeficiency and Autoimmune Disorders & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 68, co-authored 493 publications.
ORCID: 0000-0002-9259-1025Papers by this author
worksInborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 · Journal of Clinical Immunology · 1,217 citations
https://doi.org/10.1007/s10875-019-00737-x
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
2022 · Journal of Clinical Immunology · 1,078 citations
https://doi.org/10.1007/s10875-022-01289-3
Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification
2020 · Journal of Clinical Immunology · 683 citations
https://doi.org/10.1007/s10875-020-00758-x
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat